Criteria of withdrawal of first-line DMT and substitution for second-line drugs (treatment escalation) basing on MRI results (About the article A.N. Boyko, at al. «The choice of the optimal drug for pathogenic treatment of multiple sclerosis: a current state of the problem» publishe in №10(2), 2014)

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Krotenkova M.V.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Morozova S.N.

Research Center of Neurology, Russian Academy of Sciences, Moscow

Briukhov V.V.

Zavalishin I.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Peresedova A.V.

Research Center of Neurology, Moscow, Russia

Criteria of withdrawal of first-line DMT and substitution for second-line drugs (treatment escalation) basing on MRI results (About the article A.N. Boyko, at al. «The choice of the optimal drug for pathogenic treatment of multiple sclerosis: a current state of the problem» publishe in №10(2), 2014)

Authors:

Krotenkova M.V., Morozova S.N., Briukhov V.V., Zavalishin I.A., Peresedova A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(2‑2): 79‑80

DOI: 10.17116/jnevro20151152279-80

Views: 511

Downloaded: 3

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Krotenkova MV, Morozova SN, Briukhov VV, Zavalishin IA, Peresedova AV. Criteria of withdrawal of first-line DMT and substitution for second-line drugs (treatment escalation) basing on MRI results (About the article A.N. Boyko, at al. «The choice of the optimal drug for pathogenic treatment of multiple sclerosis: a current state of the problem» publishe in №10(2), 2014). S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(2‑2):79‑80. (In Russ.)
https://doi.org/10.17116/jnevro20151152279-80

Close metadata

Recommended articles:

Cognitive impairment in cerebrovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16

Validation of e-version of Russian-language expanded disability status scale (EDSS) for patients with multiple sclerosis in the Russian Federation. Medical Technologies. Assessment and Choice. 2024;(1):9-16

The effectiveness of tele-rehabilitation for patients with multiple sclerosis during the COVID-19 pandemic in 2020—2021 was evaluated in this study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):75-81

Respiratory-syncitial virus: biology, genetic diversity and perspective control preparations. Molecular Genetics, Microbiology and Virology. 2024;(1):16-24

Relapse of primary mediastinal B-cell lymphoma with isolated central nervous system involvement: risk factors and search for personalized therapy. P.A. Herzen Journal of Oncology. 2024;(2):39-45

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):86-96

A case of COVID-associated encephalopathy in a patient with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):159-163

Optical coherence tomography angiography in the diagnosis of multiple sclerosis. Russian Annals of Ophthalmology. 2024;(2):63-70

A role of cerebrovascular diseases in the progression of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57

Analysis of state guarantees for MRI in accordance with procedures for medical care approved by the Ministry of Health. Medical Technologies. Assessment and Choice. 2024;(2):69-77

Keywords:

multiple sclerosis

therapy

DMT

criteria

drug substitution

MRI

Authors:

Krotenkova M.V.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Morozova S.N.

Research Center of Neurology, Russian Academy of Sciences, Moscow

Briukhov V.V.

Zavalishin I.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Peresedova A.V.

Research Center of Neurology, Moscow, Russia

Close metadata

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.